연구

연구업적

최근 5년 연구업적 현황
연도 2025년 2024년 2023년 2022년 2021년
SCI 논문
발표편수
책임 196편 179편 173편 163편 184편
공동 132편 147편 120편 115편 136편
합계 328편 326편 293편 278편 320편
655. Regulation of MDK expression in human cancer cells modulates sensitivities to various anticancer drugs: MDK overexpression confers to a multi-drug resistance.
Kang HC, Kim IJ, Park HW, Jang SG, Ahn SA, Yoon SN, Chang HJ, Yoo BC, Park JG.
Cancer Lett. 2007 Mar 8;247(1):40-7. Link
654. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
Park HW, Kang HC, Kim IJ, Jang SG, Kim K, Yoon HJ, Jeong SY, Park JG.
Int J Cancer. 2007 Jan 1;120(1):7-12 Link
653. GSTT2 promoter polymorphisms and colorectal cancer risk.
Jang SG, Kim IJ, Kang HC, Park HW, Ahn SA, Yoon HJ, Kim K, Shin HR, Lee JS, Park JG.
BMC Cancer. 2007 Jan 25;7:16 Link
652. Development and applications of a BRAF oligonucleotide microarray.
Kim IJ, Kang HC, Jang SG, Ahn SA, Yoon HJ, Park JG.
J Mol Diagn. 2007 Feb;9(1):55-63 Link
651. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.
Kim IJ, Lim SB, Kang HC, Chang HJ, Ahn SA, Park HW, Jang SG, Park JH, Kim DY, Jung KH, Choi HS, Jeong SY, Sohn DK, Kim DW, Park JG.
Dis Colon Rectum. 2007 Sep;50(9):1342-53 Link
650. km23, a transforming growth factor-beta signaling component, is infrequently mutated in human colorectal and gastric cancers.
Kang HC, Kim IJ, Kim K, Yoon HJ, Jang SG, Park JG.
Cancer Genet Cytogenet. 2007 Jun;175(2):173-4. Link
649. Germline mutations of the MYH gene in Korean patients with multiple colorectal adenomas.
Kim DW, Kim IJ, Kang HC, Jang SG, Kim K, Yoon HJ, Ahn SA, Han SY, Hong SH, Hwang JA, Sohn DK, Jeong SY, Choi HS, Hong CW, Lim SB, Park JG.
Int J Colorectal Dis. 2007 Oct;22(10):1173-8 Link
648. The hOGG1 Ser326Cys polymorphism is not associated with colorectal cancer risk.
Park HW, Kim IJ, Kang HC, Jang SG, Ahn SA, Lee JS, Shin HR, Park JG.
J Epidemiol. 2007 Sep;17(5):156-60 Link
647. Coding region polymorphisms in the CHFR mitotic stress checkpoint gene are associated with colorectal cancer risk.
Kang HC, Kim IJ, Jang SG, Hong SH, Hwang JA, Shin HR, Park JG.
Cancer Lett. 2007 Dec 11 Link
646. Bis-styrylpyridine and bis-styrylbenzene derivatives as inhibitors for Abeta fibril formation.
Byeon SR, Lee JH, Sohn JH, Kim DC, Shin KJ, Yoo KH, Mook-Jung I, Lee WK, Kim DJ.
Bioorg Med Chem Lett. 2007 Mar 1;17(5):1466-70. Epub 2006 Nov 2 Link